Loading
CI
CannaPharmaRx, Inc. Stock: price and insider trades · Canada
No insider purchase over the last 90 days. The latest, by Herick Gary J, was filed 17 Apr 2019.
CannaPharmaRx, Inc.: what insiders have been doing
CannaPharmaRx, Inc. is a listed company. Filings by its managers are published through SEDI. Over the twelve months to 24 October 2026, 1 filing were filed, from 1 insider.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
With 1 filing in twelve months, the company is quieter than the median of 13 filings across the 2,472 companies we follow on the same exchange. Since 2019, the database holds 2 purchases and 22 sales by insiders of the company.
There has been no open-market purchase by an insider of CannaPharmaRx, Inc. for at least a year.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
40
Thresholds
n/a
Buy Volume
€872,470
2 ops. · all time
Sell Volume
€713,913
22 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 30 December 2025
Declarations40 total
Common SharesTSXSEDI:4629473
Common SharesTSXSEDI:4565167
625,725 shares@ CA$0.67100.0% of flowCommon SharesTSXSEDI:3673473
Common SharesTSXSEDI:3673465
375,000 sharesCommon SharesTSXSEDI:3613374
Common SharesTSXSEDI:3613368
1,000,000 shares@ US$0.25100.0% of flowCommon StockSEC:0001683168-20-001345:0
125,000 shares0Common StockSEC:0001128732-19-000011:0
25,000 shares@ US$1.00Common StockSEC:0001128732-19-000011:1
3,000 shares@ US$1.00Common StockSEC:0001128732-19-000011:2
10,000 shares@ US$1.00Common StockSEC:0001128732-19-000011:3
35,000 shares@ US$1.00Common StockSEC:0001128732-19-000011:4
50,000 shares@ US$1.00Common StockSEC:0001128732-19-000010:0
200,000 shares0Common StockSEC:0001128732-19-000010:1
50,000 shares0Common StockSEC:0001128732-19-000010:2
10,000 shares0Common StockSEC:0001128732-19-000010:3
50,000 shares@ US$1.00Common StockSEC:0001128732-19-000010:4
10,000 shares@ US$1.00Common StockSEC:0001128732-19-000010:5
3,000 shares@ US$1.00Common StockSEC:0001128732-19-000010:6
25,000 shares@ US$1.00Common StockSEC:0001128732-19-000010:7
10,000 shares0Common StockSEC:0001128732-19-000010:8
3,000 shares@ US$1.00Common StockSEC:0001128732-19-000010:9
3,000 shares0Common StockSEC:0001128732-19-000010:10
15,000 shares@ US$1.00Common StockSEC:0001128732-19-000010:12
100,000 shares@ US$1.00Common StockSEC:0001128732-19-000010:13
25 of 40 declarations
About CannaPharmaRx, Inc.
CannaPharmaRx, Inc. is a pharmaceutical company focused on the development of cannabis-based products. It is listed on the Toronto Stock Exchange (XTSE).
